EUVIMEDEUVIMED entdecken
Crossref

Boldine and Laurolitsine Protect against Periodontitis-Associated Bone Loss via RANKL Downregulation

Sebastián Castro-Saavedra, Gonzalo Fuentes-Barros, Carolina Rojas, Elizabeth Pellegrini, Michelle García, Marcela Hernández, Rolando Vernal, Bruce K Cassels

Planta Medica · 01.08.2026 · 92 (11) · 1030-1040

DOI: 10.1055/a-2834-4446 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.08.2026. Verfasst von Sebastián Castro-Saavedra und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Química Biodinámica, Facultad de Ciencias, Departamento de Química, Universidad de Chile, Santiago, Chile. Hauptthemen laut MEDLINE: Alveolar Bone Loss, RANK Ligand, Aporphines, Periodontitis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Periodontitis is a chronic inflammatory disease driven by dysbiosis of the subgingival microbiota, leading to immune dysregulation and progressive alveolar bone loss. In recent years, immunotherapeutic approaches, particularly those involving natural products, have gained attention as potential adjuvants to conventional therapy. This study evaluated the effects of four alkaloids, boldine, laurolitsine, laurotetanine, and N-methyl-laurotetanine, on alveolar bone loss and local immune regulation in experimental periodontitis. Male and female C57BL/6 mice with ligature-induced periodontitis received daily oral administration of each alkaloid (20 mg/kg) for 10 days. Alveolar bone loss was quantified by micro-computed tomography (micro-CT). Periodontal immune responses were assessed by RT-qPCR analysis of pro-inflammatory cytokines, T-cell-related transcription factors, and bone metabolism mediators (RANKL and OPG). In addition, regulatory T (Treg) cells in cervical lymph nodes were analyzed by flow cytometry. Boldine and laurolitsine significantly reduced alveolar bone loss compared with untreated periodontitis, in parallel with decreased RANKL expression. All four alkaloids significantly reduced IL-6 expression, with laurolitsine additionally suppressing IL-17A expression in periodontal tissues, whereas N-methyl-laurotetanine reduced IL-10 expression. No significant changes were observed in CD4+, CD4+FoxP3+, and CD4+FoxP3+CD25+ T-cell frequencies between treated and untreated groups. Oral administration of boldine and laurolitsine attenuates periodontitis-associated alveolar bone loss, likely through differential modulation of cytokine networks and osteoclastogenic signaling. These findings support their potential as host-modulating agents in the management of periodontitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alveolar Bone LossRANK LigandAporphinesPeriodontitisAnimalsMice, Inbred C57BLFemaleMaleMiceDown-RegulationAlkaloidsT-Lymphocytes, Regulatory

Substanzen

RANK LigandAporphinesboldineAlkaloidsTnfsf11 protein, mouse

Autor:innen und Institutionen

  • Laboratorio de Química Biodinámica, Facultad de Ciencias, Departamento de Química, Universidad de Chile, Santiago, Chile.
  • Laboratorio de Biología Periodontal, Facultad de Odontología, Universidad de Chile, Santiago, Chile.
  • SAPHYCHEM, Santiago, Chile.
  • Programa de Doctorado en Políticas Públicas, Universidad Mayor, Santiago, Chile.
  • Departamento de Patología y Medicina Oral, Facultad de Odontología, Universidad de Chile, Santiago, Chile.
  • Departamento de Odontología Conservadora, Facultad de Odontología, Universidad de Chile, Santiago, Chile.

Zitieren

APA

Castro-Saavedra, S., Fuentes-Barros, G., Rojas, C., Pellegrini, E., García, M., Hernández, M., Vernal, R., & Cassels, B. K. (2026). Boldine and Laurolitsine Protect against Periodontitis-Associated Bone Loss via RANKL Downregulation. Planta Medica, 92(11), 1030-1040. https://doi.org/10.1055/a-2834-4446

Vancouver

Castro-Saavedra S, Fuentes-Barros G, Rojas C, Pellegrini E, García M, Hernández M, et al. Boldine and Laurolitsine Protect against Periodontitis-Associated Bone Loss via RANKL Downregulation. Planta Medica. 2026;92(11):1030-1040. doi:10.1055/a-2834-4446

BibTeX
@article{CastroSaavedra2026,
  author = {Castro-Saavedra, Sebastián and Fuentes-Barros, Gonzalo and Rojas, Carolina and Pellegrini, Elizabeth and García, Michelle and Hernández, Marcela and Vernal, Rolando and Cassels, Bruce K},
  title = {Boldine and Laurolitsine Protect against Periodontitis-Associated Bone Loss via RANKL Downregulation},
  journal = {Planta Medica},
  year = {2026},
  volume = {92},
  number = {11},
  pages = {1030--1040},
  doi = {10.1055/a-2834-4446}
}
Kostenlos starten →